Cite
Barkama R, Mayo A, Paz A, et al. Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019. Crit Care Explor. 2020;2(9):e0207doi: 10.1097/CCE.0000000000000207.
Barkama, R., Mayo, A., Paz, A., Solopov, A., Mann, T., Vadasz, Z., Appel, T., Ofir, R., Shani, L., Sheleg, M., Allen, H., Shaked Nitzan, R., Tsarfaty, N., Gilad, H., Birch, T., Kachel, E., Reinke, P., Volk, H. D., Zalts, R., & Raz Pasteur, A. (2020). Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019. Critical care explorations, 2(9), e0207. https://doi.org/10.1097/CCE.0000000000000207
Barkama, Ravit, et al. "Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019." Critical care explorations vol. 2,9 (2020): e0207. doi: https://doi.org/10.1097/CCE.0000000000000207
Barkama R, Mayo A, Paz A, Solopov A, Mann T, Vadasz Z, Appel T, Ofir R, Shani L, Sheleg M, Allen H, Shaked Nitzan R, Tsarfaty N, Gilad H, Birch T, Kachel E, Reinke P, Volk HD, Zalts R, Raz Pasteur A. Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019. Crit Care Explor. 2020 Sep 15;2(9):e0207. doi: 10.1097/CCE.0000000000000207. eCollection 2020 Sep. PMID: 32984833; PMCID: PMC7498138.
Copy
Download .nbib